middle.news
Orthocell Raises $30M to Accelerate US Rollout of Nerve Repair Innovation
9:27am on Friday 17th of October, 2025 AEDT
•
Healthcare
Read Story
Orthocell Raises $30M to Accelerate US Rollout of Nerve Repair Innovation
9:27am on Friday 17th of October, 2025 AEDT
Key Points
Raised $30 million via institutional placement at $1.30 per share
Funds to accelerate US rollout of Remplir post-FDA clearance in 2025
Expansion of manufacturing capacity from 100,000 to 400,000 units annually
Clinical studies targeting prostate cancer surgery applications
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Orthocell (ASX:OCC)
OPEN ARTICLE